NCT05203302 Novel Coding Strategies for Children With Cochlear Implants
| NCT ID | NCT05203302 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Deafness |
| Study Type | INTERVENTIONAL |
| Enrollment | 190 participants |
| Start Date | 2018-07-12 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 190 participants in total. It began in 2018-07-12 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to understand performance with a cochlear implant. The long-term goals of this research are to improve sound perception with cochlear implants and to better understand the functioning of the auditory system. Information from individuals with and without cochlear implants will be compared.
Eligibility Criteria
Inclusion Criteria: * Be 7 years of age or older and pre-lingually implanted with a cochlear implant (before the age of 2 years), have aided residual hearing, or have normal hearing. * Be ages 18 or older and post-lingually implanted or have normal hearing. * Be ages 18-35 and pre-lingually implanted. Exclusion Criteria: * Any child implanted post-lingually
Contact & Investigator
David M Landsberger, MD
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT05203302 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 80 Years, studying Deafness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05203302 currently recruiting?
Yes, NCT05203302 is actively recruiting participants. Contact the research team at david.landsberger@nyulangone.org for enrollment information.
Where is the NCT05203302 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT05203302 clinical trial?
NCT05203302 is sponsored by NYU Langone Health. The principal investigator is David M Landsberger, MD at NYU Langone Health. The trial plans to enroll 190 participants.